Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-22-Speech-1-176"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20101122.17.1-176"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Madam President, I am pleased that the Commission started by pointing out precisely the fact that access to information on medicinal products currently varies enormously throughout Europe, because we have tried very hard to ensure that everyone has good access and to harmonise this access. At the same time, I had a requirement of my own and that was that the information must not be worse or sparser in any particular country. I know that this is something that many people were concerned about in some countries, including Sweden, where, for a long time, we have had a system called Fass. I will now address those people directly and say that the way Parliament has voted here not only means that it is possible to retain Fass, but it is also possible for other countries to introduce similar systems.
In other respects, of course, the rules in Europe today are rather strange in that anyone can say whatever they like about medicinal products that are subject to medical prescription except those who manufacture these medicinal products; in other words, those who should know most about them. I am therefore pleased that we have established that they not only have the right, they actually have a duty to disseminate certain basic information. They must also contribute, because after all, they are the ones sitting on a lot of the information.
To the Commissioner I would simply like to say that I am very pleased to see that you and I seem to agree on all of the points that are key for me in this work. I believe that the Commission and Parliament are now in agreement. This puts considerable pressure on the Council to take up this matter in a constructive way and work further on it. To be honest, even with regard to the points in the proposal to which the Commission has stated that it has objections, I would maintain that the essence of what we want to achieve is very similar, for example, as regards printed material and the possibility of helping those countries that have constitutional problems, including Sweden, to solve them in the proposal.
Finally, I would like simply to address those Members here who do not think that we should have an exception for doctors and the information that doctors are to provide. Personally, I think that a doctor who sees a clinical trial published by a company should have the right to give it to a patient if the doctor deems the information to be relevant, or that a doctor who finds a package leaflet in a language other than that Member States’ official language should have the right to print out that information and give it to a patient. In that case, however, we must vote for the doctor himself to be able to decide and not for this directive to govern what doctors are to give to patients. It is always the doctors’ responsibility and we should not regulate it here."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples